OPEN TTG
Dead / Cancelled — Cancelled — Section 8 (as of 24 Sept 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85032922
- Registration number
- 3922441
- Mark type
- Stylized text
- Filed
- 07 May 2010
- Published for opposition
- 07 Dec 2010
- Registered
- 22 Feb 2011
- Attorney of record
- Dwayne K. Goetzel
Goods and services
- Class 001 — Chemicals: Chemicals and biochemicals used in industry and science, chemicals and biochemicals for apheresis
- Class 005 — Pharmaceuticals: Medicines, pharmaceutical, veterinary and sanitary preparations for the treatment, prophylaxis and diagnosis of diseases; (( pharmaceutical preparations in particular for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; chemical and biochemical preparations for medicinal purposes, chemical and biochemical preparations for sanitary purposes, chemical and biochemical preparations for medical and veterinary purposes, all the aforementioned for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; dietetic foods adapted for medical use and dietetic foods for medical and veterinary purposes; food supplements for medical purposes; disinfectants for sanitary purposes; preparations for destroying vermin; chemical and biochemical preparations for use in medical science for use in or on human and/or animal bodies for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; diagnostic preparations for medical purposes; radiological contrast agents for medical purposes, germicidal detergents for medical purposes, pharmaceutical preparations for apheresis ))
Owner
- Zedira GmbH, Darmstadt, DE
- Zedira GmbH, Darmstadt, DE
- Zedira GmbH, Darmstadt, DE
Prosecution history
- 24 Sept 2021 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 22 Feb 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 25 Jan 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 25 Jan 2017 — SEC. 15 ACKNOWLEDGEMENT - E-MAILED
- 25 Jan 2017 — REGISTERED - SEC. 15 ACKNOWLEDGED
- 25 Jan 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 25 Jan 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Jan 2017 — TEAS SECTION 15 RECEIVED
- 12 Jan 2017 — TEAS SECTION 8 RECEIVED
- 22 Feb 2011 — REGISTERED-PRINCIPAL REGISTER
- 07 Dec 2010 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Dec 2010 — PUBLISHED FOR OPPOSITION
- 02 Nov 2010 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 02 Nov 2010 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Nov 2010 — EXAMINER'S AMENDMENT ENTERED